cosmos-logo.jpg
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.25 Million of Debt into Common Stock at $6.00 Per Share
July 26, 2021 09:25 ET | Cosmos Holdings
CHICAGO, July 26, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic...
cosmos-logo.jpg
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.0 Million of Debt into Common Stock at $6.00 Per Share
July 16, 2021 09:38 ET | Cosmos Holdings
CHICAGO, July 16, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic...
cosmos-logo.jpg
Cosmos Holdings Signs Exclusive Distribution Agreement with Mediprovita GbR for Launch of Sky Premium Life Products in Germany and Austria
July 08, 2021 09:25 ET | Cosmos Holdings
First Phase Launches Sky Premium Life Products on Amazon and eBay; Second Phase Launch Includes Brick & Mortar Stores Continues to Expand its Network of European Distribution Partners; Plans to...
cosmos-logo.jpg
Cosmos Holdings Appoints Finance Veteran Alexi Papaconstantinou to its Advisory Board
July 01, 2021 09:15 ET | Cosmos Holdings
CHICAGO, July 01, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic...
cosmos-logo.jpg
Cosmos Holdings CEO Greg Siokas Converts $3.0 Million of Debt into Common Stock at $6.00 Per Share
June 28, 2021 09:25 ET | Cosmos Holdings
CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic...
cosmos-logo.jpg
Cosmos Holdings Provides First Quarter 2021 Business Update; Reports 89% Year-Over-Year and 60% Sequential Increase in Nutraceutical Business
May 18, 2021 09:00 ET | Cosmos Holdings
CHICAGO, May 18, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and...
cosmos-logo.jpg
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon UK
April 27, 2021 09:15 ET | Cosmos Holdings
CHICAGO, April 27, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and...
cosmos-logo.jpg
Cosmos Holdings Reports Revenue Growth of 40% to a Record $55.4 Million and Achieves Profitability for 2020
April 16, 2021 09:15 ET | Cosmos Holdings
CHICAGO, April 16, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and...
Sky Premium Life King Eros and Queen Venus Supplements
Cosmos Holdings Launches Proprietary King Eros and Queen Venus Supplements for Enhanced Libido
April 14, 2021 09:16 ET | Cosmos Holdings
King Eros supplement formula developed to improve sexual health and men’s libido Queens Venus is a complete nutritional supplement for women designed to increase energy and libido CHICAGO, April ...